William Housley

Affiliations

AbbVie, North Chicago, IL, USA.

Publications (2)

Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trial.

The Lancet. Rheumatology

Avec: Roy Fleischmann , Alan Friedman , Edit Drescher , Atul Singhal , Gregorio Cortes-Maisonet , Thao Doan , Wenjing Lu , Zailong Wang , Ahmed Nader , Stanley Cohen , Peter C Taylor , Ricardo Blanco

Synovial Inflammatory Pathways Characterize Anti-TNF-Responsive Rheumatoid Arthritis Patients.

Arthritis & rheumatology (Hoboken, N.J.)

Avec: Jing Wang , Donna Conlon , Felice Rivellese , Alessandra Nerviani , Myles J Lewis , Marc C Levesque , Xiaohong Cao , Carolyn Cuff , Andrew Long , Costantino Pitzalis , Melanie C Ruzek

Réseau de co-auteurs

Roy Fleischmann 1 collaboration

Alan Friedman 1 collaboration

Edit Drescher 1 collaboration

Atul Singhal 1 collaboration

Gregorio Cortes-Maisonet 1 collaboration

Thao Doan 1 collaboration

Wenjing Lu 1 collaboration

Zailong Wang 1 collaboration

Ahmed Nader 1 collaboration

Stanley Cohen 1 collaboration

Peter C Taylor 1 collaboration

Ricardo Blanco 1 collaboration

Jing Wang 1 collaboration

Donna Conlon 1 collaboration

Felice Rivellese 1 collaboration

Alessandra Nerviani 1 collaboration

Myles J Lewis 1 collaboration

Marc C Levesque 1 collaboration

Xiaohong Cao 1 collaboration

Carolyn Cuff 1 collaboration

Andrew Long 1 collaboration

Costantino Pitzalis 1 collaboration

Melanie C Ruzek 1 collaboration